0001209191-23-042247.txt : 20230713 0001209191-23-042247.hdr.sgml : 20230713 20230713202820 ACCESSION NUMBER: 0001209191-23-042247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230711 FILED AS OF DATE: 20230713 DATE AS OF CHANGE: 20230713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Henderson Jeffrey William CENTRAL INDEX KEY: 0001324015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 231087796 MAIL ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-11 0 0000921299 FIBROGEN INC FGEN 0001324015 Henderson Jeffrey William C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158 1 0 0 0 1 Common Stock 2023-07-11 4 S 0 2000 2.69 D 32866 D Shares sold by the reporting person pursuant to a 10b5-1 trading plan. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.66 to $2.735. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-07-13